Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Body Weight Reduction Associated with the Sibutramine Treatment: Overall Results of the PRIMAVERA Primary Health Care Trial.

Dedov II, Melnichenko GA, Troshina EA, Mazurina NV, Galieva MO.

Obes Facts. 2018;11(4):335-343. doi: 10.1159/000488880. Epub 2018 Aug 9.

2.

[Long-term consequences of polycystic ovary syndrome].

Grigoryan OR, Zhemaite NS, Volevodz NN, Andreeva EN, Melnichenko GA, Dedov II.

Ter Arkh. 2017;89(10):75-79. doi: 10.17116/terarkh2017891075-79. Review. Russian.

PMID:
29171475
3.

[Shereshevsky-Turner syndrome: Estrogen replacement therapy and cardiovascular risk factors].

Yevstigneeva OA, Andreeva EN, Grigoryan OR, Volevodz NN, Melnichenko GA, Dedov II.

Ter Arkh. 2017;89(10):48-53. doi: 10.17116/terarkh2017891048-53. Russian.

PMID:
29171470
4.

Effects of endogenous hypercortisolism on bone mRNA and microRNA expression in humans.

Belaya ZE, Grebennikova TA, Melnichenko GA, Nikitin AG, Solodovnikov AG, Brovkina OI, Grigoriev AU, Rozhinskaya LY, Dedov II.

Osteoporos Int. 2018 Jan;29(1):211-221. doi: 10.1007/s00198-017-4241-7. Epub 2017 Oct 4.

PMID:
28980049
5.

[Incretin secretion and glucose metabolism in morbidly obese patients in the early and late periods after biliopancreatic diversion].

Dedov II, Melnichenko GA, Troshina EA, Ershova EV, Mazurina NV, Ogneva NA, Yashkov YI, Ilyin АV.

Ter Arkh. 2016;88(10):9-18. doi: 10.17116/terarkh201688109-18. Russian.

PMID:
27801414
6.

Diagnostic performance of osteocalcin measurements in patients with endogenous Cushing's syndrome.

Belaya ZE, Iljin AV, Melnichenko GA, Solodovnikov AG, Rozhinskaya LY, Dzeranova LK, Dedov II.

Bonekey Rep. 2016 Jun 15;5:815. doi: 10.1038/bonekey.2016.42. eCollection 2016.

7.

[Role of microRNA in oncogenesis of pituitary tumors and their practical significance].

Lapshina AM, Khandaeva PM, Belaya ZE, Rozhinskaya LY, Melnichenko GA.

Ter Arkh. 2016;88(8):115-120. doi: 10.17116/terarkh2016888115-120. Review. Russian.

PMID:
28635944
8.

[The canonical Wnt/β-catenin pathway: From the history of its discovery to clinical application].

Grebennikova TA, Belaya ZE, Rozhinskaya LY, Melnichenko GA.

Ter Arkh. 2016;88(10):74-81. doi: 10.17116/terarkh201688674-81. Review. Russian.

PMID:
28635854
9.

The risk factors for fractures and trabecular bone-score value in patients with endogenous Cushing's syndrome.

Belaya ZE, Hans D, Rozhinskaya LY, Dragunova NV, Sasonova NI, Solodovnikov AG, Tsoriev TT, Dzeranova LK, Melnichenko GA, Dedov II.

Arch Osteoporos. 2015;10:44. doi: 10.1007/s11657-015-0244-1. Epub 2015 Nov 25.

PMID:
26608406
10.

[Familial partial lipodystrophy (Dunnigan syndrome) due to LMNA gene mutation: The first description of its clinical case in Russia].

Sorkina EL, Kalashnikova MF, Melnichenko GA, Tyulpakov AN.

Ter Arkh. 2015;87(3):83-87. doi: 10.17116/terarkh201587383-87. Russian.

PMID:
26027246
11.

[Features of the mental state of obese patients with concomitant sleep disorders].

Strueva NV, Gegel NV, Poluektov MG, Savelyeva LV, Melnichenko GA, Bobrov AE.

Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(11):88-91. Russian.

PMID:
25591643
12.

[Carbohydrate metabolism in patients with acromegaly and Itsenko-Cushing disease].

Matchekhina LV, Belaya ZE, Melnichenko GA, Shestakova MV.

Ter Arkh. 2015;87(10):98-104. doi: 10.17116/terarkh2015871098-104. Russian.

PMID:
28635800
13.

[Pathophysiological aspects of wound healing in normal and diabetic foot].

Maksimova NV, Lyundup AV, Lubimov RO, Melnichenko GA, Nikolenko VN.

Vestn Ross Akad Med Nauk. 2014;(11-12):110-7. Review. Russian.

PMID:
25971136
14.

Serum extracellular secreted antagonists of the canonical Wnt/β-catenin signaling pathway in patients with Cushing's syndrome.

Belaya ZE, Rozhinskaya LY, Melnichenko GA, Solodovnikov AG, Dragunova NV, Iljin AV, Dzeranova LK, Dedov II.

Osteoporos Int. 2013 Aug;24(8):2191-9. doi: 10.1007/s00198-013-2268-y. Epub 2013 Jan 29.

PMID:
23358608
15.

Clinical significance of TSH circadian variability in patients with hypothyroidism.

Sviridonova MA, Fadeyev VV, Sych YP, Melnichenko GA.

Endocr Res. 2013;38(1):24-31. doi: 10.3109/07435800.2012.710696. Epub 2012 Aug 2.

PMID:
22857384
16.

Practical evaluation of late-night salivary cortisol: a real-life approach.

Belaya ZE, Melnichenko GA.

Endocrine. 2012 Aug;42(1):222-3; author reply 224-5. doi: 10.1007/s12020-012-9709-9. No abstract available.

PMID:
22644839
17.

Diagnostic performance of late-night salivary cortisol measured by automated electrochemiluminescence immunoassay in obese and overweight patients referred to exclude Cushing's syndrome.

Belaya ZE, Iljin AV, Melnichenko GA, Rozhinskaya LY, Dragunova NV, Dzeranova LK, Butrova SA, Troshina EA, Dedov II.

Endocrine. 2012 Jun;41(3):494-500. doi: 10.1007/s12020-012-9658-3. Epub 2012 Mar 25.

PMID:
22447310
18.

Combined therapy with L-thyroxine and L-triiodothyronine compared to L-thyroxine alone in the treatment of primary hypothyroidism.

Fadeyev VV, Morgunova TB, Melnichenko GA, Dedov II.

Hormones (Athens). 2010 Jul-Sep;9(3):245-52.

19.
20.

Use of the NuvaRing hormone-releasing system in late reproductive-age women with type 1 diabetes mellitus.

Grigoryan OR, Grodnitskaya EE, Andreeva EN, Chebotnikova TV, Melnichenko GA.

Gynecol Endocrinol. 2008 Feb;24(2):99-104. doi: 10.1080/09513590701708795.

PMID:
18210334

Supplemental Content

Loading ...
Support Center